Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.

Cytokines, cellular & molecular therapy - 1 Dec 1999

Keeffe E B, Dusheiko G M, Tong M J, Hollinger F B, Heathcote E J, McHutchison J, Albert D

Abstract excerpt

We assessed differences in the pattern of HCV RNA decrease for HCV genotypes 1, 2, and 3 during interferon treatment to determine if the lower response rates observed among genotype 1 patients were related to a slower decrease in HCV clearance. Serum HCV RNA values of 472 chronic hepatitis C patients treated with either consensus interferon (CIFN) or interferon alfa-2b (IFN alfa-2b) were evaluated. Neither...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Interferon Type I

Share to Recombinant Proteins

Share to RNA, Viral

Source

Identifiers

PMID: 10850385

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.PMID 10850385Read ↗

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.Semantic proximity Read ↗

Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon.Semantic proximity Read ↗

Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.Semantic proximity Read ↗

Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype.Semantic proximity Read ↗

Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C.Semantic proximity Read ↗

Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapse.Semantic proximity Read ↗

Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.Semantic proximity Read ↗

Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection.Semantic proximity Read ↗

Utility of hepatitis C virus RNA levels for predicting the therapeutic efficacy of interferon.Semantic proximity Read ↗

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.